Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Dual or Triple Therapy for Maintenance of COPD: A Review
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
2
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
3
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
4
Using Complement Inhibitors in GA Comes With Pros and Cons
5